Phio Pharmaceuticals Corp. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Phio Pharmaceuticals Corp. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q2 2024.
  • Phio Pharmaceuticals Corp. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 510K shares, a 74.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 510K -1.48M -74.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.59M +3.44M +299% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 416K -723K -63.4% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 2.31M -11.4M -83.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.99M -11.7M -85.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 1.15M -12.5M -91.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.14M +11.1K +0.99% Dec 31, 2022 10-K 2024-04-01
Q3 2022 13.7M +133K +0.99% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 13.7M +124K +0.92% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 13.7M +124K +0.92% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 1.13M -4.65M -80.5% Dec 31, 2021 10-K 2023-03-22
Q3 2021 13.5M +7.75M +134% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 13.5M +7.75M +134% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 13.5M +10.7M +372% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 5.78M +5.11M +764% Dec 31, 2020 10-K 2022-03-22
Q3 2020 5.78M -19.9M -77.5% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 5.78M -19.3M -77% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 2.87M -20.5M -87.7% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 669K +327K +95.4% Dec 31, 2019 10-K 2021-03-25
Q3 2019 25.7M +21.2M +477% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 25.1M +20.7M +475% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 23.4M +20.7M +766% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 343K -2.09M -85.9% Dec 31, 2018 10-K 2020-03-26
Q3 2018 4.45M +2.08M +87.8% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 4.36M +2.04M +87.6% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 2.7M +495K +22.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 2.43M +1.13M +86.9% Dec 31, 2017 10-K 2019-03-27
Q3 2017 2.37M -4.23M -64.1% Sep 30, 2017 10-Q/A 2018-03-26
Q2 2017 2.32M -4.21M -64.4% Jun 30, 2017 10-Q/A 2018-03-26
Q1 2017 2.2M -4.33M -66.3% Mar 31, 2017 10-Q/A 2018-03-26
Q4 2016 1.3M -5.23M -80.1% Dec 31, 2016 10-K 2018-03-26
Q3 2016 6.6M -58.3M -89.8% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 6.53M -58.4M -89.9% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 6.53M -24.7M -79.1% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 6.53M -15.4M -70.3% Dec 31, 2015 10-K 2017-03-30
Q3 2015 64.9M +43.8M +207% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 64.9M +50M +336% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 31.2M +17.8M +133% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 22M +10.2M +86.5% Dec 31, 2014 10-K 2016-03-30
Q3 2014 21.1M +9.45M +80.9% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 14.9M +3.46M +30.2% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 13.4M -308M -95.8% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 11.8M +6.5M +123% Dec 31, 2013 10-K 2015-03-30
Q3 2013 11.7M -88.8M -88.4% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 11.4M -89M -88.6% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 322M +221M +220% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 5.29M -95.2M -94.7% Dec 31, 2012 10-K 2014-03-28
Q3 2012 100M Sep 30, 2012 10-Q 2012-11-13
Q2 2012 100M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 100M Dec 31, 2011 10-K 2013-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.